Multiparametric ultrasound as a new concept of assessment of liver tissue damage
Authors:
Open Access
- 28 March 2024
- journal article
- editorial
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (12) , 1663-1669
Abstract
Liver disease accounts for approximately 2 million deaths per year worldwide. All chronic liver diseases (CLDs), whether of toxic, genetic, autoimmune, or infectious origin, undergo typical histological changes in the structure of the tissue. These changes may include the accumulation of extracellular matrix material, fats, triglycerides, or tissue scarring. Noninvasive methods for diagnosing CLD, such as conventional B-mode ultrasound (US), play a significant role in diagnosis. Doppler US, when coupled with B-mode US, can be helpful in evaluating the hemodynamics of hepatic vessels and detecting US findings associated with hepatic decompensation. US elastography can assess liver stiffness, serving as a surrogate marker for liver fibrosis. It is important to note that interpreting these values should not rely solely on a histological classification. Contrast-enhanced US (CEUS) provides valuable information on tissue perfusion and enables excellent differentiation between benign and malignant focal liver lesions. Clinical evaluation, the etiology of liver disease, and the patient current comorbidities all influence the interpretation of liver stiffness measurements. These measurements are most clinically relevant when interpreted as a probability of compensated advanced CLD. B-mode US offers a subjective estimation of fatty infiltration and has limited sensitivity for mild steatosis. The controlled attenuation parameter requires a dedicated device, and cutoff values are not clearly defined. Quan-titative US parameters for liver fat estimation include the attenuation coefficient, backscatter coefficient, and speed of sound. These parameters offer the advantage of providing fat quantification alongside B-mode evaluation and other US parameters. Multiparametric US (MPUS) of the liver introduces a new concept for complete noninvasive diagnosis. It encourages examiners to utilize the latest features of an US machine, including conventional B-mode, liver stiffness evaluation, fat quantification, dispersion imaging, Doppler US, and CEUS for focal liver lesion characterization. This comprehensive approach allows for diagnosis in a single examination, providing clinicians worldwide with a broader perspective and becoming a cornerstone in their diagnostic arsenal. MPUS, in the hands of skilled clinicians, becomes an invaluable predictive tool for diagnosing, staging, and monitoring CLD.Keywords
This publication has 21 references indexed in Scilit:
- Global burden of liver disease: 2023 updateJournal of Hepatology, 2023
- The Natural History of Advanced Chronic Liver Disease Defined by Transient ElastographyClinical Gastroenterology and Hepatology, 2022
- Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trialsJournal of Hepatology, 2020
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issuesMolecular Aspects of Medicine, 2019
- Clinical states of cirrhosis and competing risksJournal of Hepatology, 2018
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracyJournal of Hepatology, 2011
- Liver biopsy: The best, not the gold standardJournal of Hepatology, 2009
- Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2007
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006